Treatment schedules for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Treatment schedules for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration

Published:2016-05-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Li Emily¹,Donati Simone²,Virgili Gianni³,Krzystolik Magdalena G⁴

Affiliation:

1. Signature Healthcare Brockton Hospital; Transitional Year Residency Program; 680 Centre Street Brockton Massachusetts USA 02302

2. University of Insubria, Varese-Como; Department of Surgical and Morphological Sciences, Section of Ophthalmology; Via Guicciardini 9 Varese Italy 21100

3. University of Florence; Department of Translational Surgery and Medicine, Eye Clinic; Largo Brambilla, 3 Florence Italy 50134

4. Mass Eye and Ear Infirmary; Department of Ophthalmology, Retina Service; 1 Randall Square, Suite 203 Providence Rhode Island USA 02904

Publisher

Wiley

Subject

Pharmacology (medical)

Reference51 articles.

1. Chronic visual loss;Harper,2010

2. American Academy of Ophthalmology Age-related macular degeneration eyewiki.aao.org/Age-related_macular_degeneration

3. Anti-VEGF treatment in neovascular age-related macular degeneration;Abedi;Retina,2014

4. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study;Brown;Ophthalmology,2009

5. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010;Bourne;British Journal of Ophthalmology,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contralateral Effect following Intravitreal Brolucizumab Injection in Diabetic Macular Edema;Case Reports in Ophthalmological Medicine;2022-01-28

2. Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study;Clinical Ophthalmology;2021-09

3. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration;Cochrane Database of Systematic Reviews;2020-05-05

4. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration;Cochrane Database of Systematic Reviews;2019-03-04